CMTM4 is a subunit of the IL-17 receptor and mediates autoimmune pathology.

Nat Immunol · 2022 · PMC9663306 · PMID 36271145

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Cmtm4 −/− mice had a slightly milder EAE progression, based on the combined severity score, compared to Cmtm4 +/+ littermates, albeit the difference did not reach statistical significance (Extended Data Fig. 8f ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.